NCT06781749 New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
| NCT ID | NCT06781749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Hearing Loss, Bilateral (Causes Other Than Tumors) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if hearing devices, like hearing aids, affect social and cognitive function of older adults. The main questions the researchers want to answer are: * How social are older adults with hearing loss before and after using hearing devices? * How well do older adults with hearing loss think before and after using hearing devices? * For older adults who have hearing loss and use hearing devices, do changes in social interaction explain changes in how well they think (cognitive function)? * Do brainwaves (EEGs) in older adults with hearing loss change after using hearing devices? * Are there differences in how social older adults with hearing loss are compared to older adults without hearing loss? What Participants Will Do: * Participants will take questionnaires for around 60 minutes. Questionnaires will ask participants about their background, health, hearing, and how social they are. Another set of questionnaires will check their thinking ability or cognition. * Participants will wear an audio sensor (TILES Audio Recorder on Jelly Mobile phone) for 2 weeks. The sensor will collect and store information about a participant's voice during conversations. Once the device has information about a participant's voice such as pitch and tone it will store this information and delete the audio recording. Words spoken during conversations will be deleted. * (Optional) Participants can choose to participate in a 45-60-minute EEG (electroencephalogram) recording session. Participants will have sensors placed on top of their heads. Sensors will record the participants' brainwaves. Sounds will be played to see how participants' brainwaves change when they hear sounds. Eligible participants will be invited to participate in 4-month follow-up study.
Eligibility Criteria
Inclusion Criteria: * Age \>= 60 years * English or Spanish speaking * Group 1- older adults with normal hearing defined as speech frequency PTA \<25dB HL in bilateral ears * Group 2- older adults with bilateral hearing loss who are not using hearing aids * Group 3- older adults with bilateral hearing loss, who are currently using hearing aids Exclusion Criteria: * Age \<60 years * Unable to complete questionnaires in English or Spanish
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06781749 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Hearing Loss, Bilateral (Causes Other Than Tumors). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06781749 currently recruiting?
Yes, NCT06781749 is actively recruiting participants. Contact the research team at janet.choi@med.usc.edu for enrollment information.
Where is the NCT06781749 trial being conducted?
This trial is being conducted at Los Angeles, United States, Los Angeles, United States.
Who is sponsoring the NCT06781749 clinical trial?
NCT06781749 is sponsored by University of Southern California. The trial plans to enroll 100 participants.